![2023 News - Aspirin as Effective as Blood Thinner Injections to Prevent Deadly Complications in Patients Hospitalized with Bone Fractures | University of Maryland School of Medicine 2023 News - Aspirin as Effective as Blood Thinner Injections to Prevent Deadly Complications in Patients Hospitalized with Bone Fractures | University of Maryland School of Medicine](https://www.medschool.umaryland.edu/media/SOM/News/2023/Asprin-Fracture-Banner.jpg)
2023 News - Aspirin as Effective as Blood Thinner Injections to Prevent Deadly Complications in Patients Hospitalized with Bone Fractures | University of Maryland School of Medicine
![Aspirin Use to Prevent 1st Heart Attack or Stroke Should Be Curtailed, U.S. Panel Says - The New York Times Aspirin Use to Prevent 1st Heart Attack or Stroke Should Be Curtailed, U.S. Panel Says - The New York Times](https://static01.nyt.com/images/2021/10/12/science/12aspirin/12aspirin-videoSixteenByNineJumbo1600.jpg)
Aspirin Use to Prevent 1st Heart Attack or Stroke Should Be Curtailed, U.S. Panel Says - The New York Times
![Comparison Between Aspirin and Clopidogrel in Secondary Stroke Prevention Based on Real‐World Data | Journal of the American Heart Association Comparison Between Aspirin and Clopidogrel in Secondary Stroke Prevention Based on Real‐World Data | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/cc638510-4402-4bfc-80cc-fab260c5b1b0/jah33568-fig-0001.png)
Comparison Between Aspirin and Clopidogrel in Secondary Stroke Prevention Based on Real‐World Data | Journal of the American Heart Association
![Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial - The Lancet Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial - The Lancet](https://www.thelancet.com/cms/attachment/b3c2a7a1-c285-44fd-a34d-53013b254610/gr1.gif)